UNI-EN 41:Current report re insiders transactions - 41-Donev
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 41 | / | 2014 | | ||||||
Date of issue: | 2014-04-14 | ||||||||||
Short name of the issuer | |||||||||||
SOPHARMA AD | |||||||||||
Subject | |||||||||||
Current report re insiders transactions - 41-Donev | |||||||||||
Official market - legal basis | |||||||||||
Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
SOPHARMA AD (the “Company") announces that it was notified by Mr Ognian Donev, Chairman of the Board of Directors that he, executed the following transactions related to shares in the Company: Date and time Operation Number Unit price of the of shares (BGN) settlement 9.4.2014 Buy 1 000 4.5110 15.4.2014 Buy 200 4.4700 15.4.2014 Buy 100 4.4700 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
Current report re insiders transactions - 41-Donev.doc Current report re insiders transactions - 41-Donev.doc | Current report re insiders transactions - 41-Donev |
SOPHARMA AD | |||||||||||||
(fullname of the issuer) | |||||||||||||
SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
1220 | Sofia | ||||||||||||
(post code) | (city) | ||||||||||||
IlienskoShosse | 16 | ||||||||||||
(street) | (number) | ||||||||||||
+359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nd | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2014-04-14 | Ognian Donev | Executive director |
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 9.0 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.